4Filed Aug 24, 8:00 PM ET
Mineralys (MLYS) CCO Warren Eric Exercises Options and Sells Shares
$MLYS · Mineralys Therapeutics, Inc.Research Summary
AI-generated summary of this SEC filing
Mineralys (MLYS) CCO Warren Eric Exercises Options and Sells Shares
What Happened
- Warren Eric, Chief Commercial Officer, exercised stock options to acquire 7,437 shares at $13.24 per share (total cost $98,466) and sold those 7,437 shares in the open market at a weighted-average price of $25.98 per share (gross proceeds $193,189). The transactions were reported for 2026-08-21.
- The Form 4 also records a derivative disposition for 7,437 shares at $0, reflecting the option conversion/settlement related to the exercise.
Key Details
- Transaction date: August 21, 2026.
- Exercise (code M, Acquired): 7,437 shares @ $13.24 = $98,466.
- Sale (code S, Disposed): 7,437 shares @ weighted-average $25.98 (prices ranged $25.82–$26.15) = $193,189. (Reporting person can provide per-price breakdown on request.) [F2]
- Derivative disposition (code M, Disposed): 7,437 shares @ $0 (reflects conversion/settlement).
- Sale executed pursuant to a Rule 10b5-1 selling plan adopted March 27, 2026. [F1]
- Vesting note: the option vests 25% after one year, then monthly over 36 months. [F3]
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Filing: Form 4 filed Aug 25, 2026 for transactions on Aug 21, 2026 — appears timely (no late filing flag reported).
Context
- This was an exercise of stock options followed by immediate sale of the resulting shares (i.e., essentially a cashless outcome where proceeds exceed exercise cost). For clarity: code M denotes option exercise/conversion; code S denotes a sale.
- The sale was made under a pre-arranged 10b5-1 plan, which is a routine mechanism insiders use to sell shares on a scheduled basis rather than a market-timing decision.